05/09/2026
Delayed-onset nodules cannot be managed safely through protocol alone.
On 16 September, Mr James Olding will lead CPD webinar, exclusively for Interface Level 7 delegates.
This evidence-led session will examine the classification, diagnosis and management of nodules following injectable treatment — including the distinction between early- and delayed-onset presentations, differences across product types and the importance of constructing an appropriate differential diagnosis.
Delegates will also critically examine the strength of the evidence behind current management approaches, alongside essential documentation and reporting responsibilities.
The session provides one hour of participatory CPD and is mapped to GDC, NMC and GMC frameworks.
Completion will include attendance, a post-session assessment and reflective feedback.
Access details will be shared directly with eligible Level 7 delegates.